---
layout: post
title: "Leading artificial intelligence companies partner on a quest to solve Duchenne Muscular Dystrophy"
date: 2018-07-28
categories: Technology
author: unknown author
tags: [Medication, Drug discovery, Artificial intelligence, Duchenne muscular dystrophy, Insilico Medicine, Muscular dystrophy, Medicine, Health sciences, Biology, Life sciences, Clinical medicine, Health, Biotechnology, Medical specialties]
---




#### Extract
>(InSilico Medicine, Inc.) Insilico Medicine announced a research collaboration agreement with A2A Pharmaceuticals, Inc. The two parties agreed to create a new company called 'Consortium.AI', which will apply the latest advances in AI to discovery of novel small molecules for the Duchenne Muscular Dystrophy (DMD) and other rare orphan diseases....



[Visit Link](https://www.eurekalert.org/pub_releases/2018-07/imi-lai071718.php)


